PARP1 and neoplasm: PARP inhibition functions by compromising the ability of tumor cells to repair DNA single-strand breaks, resulting in the accumulation of double-strand breaks (DSBs), which lead to genomic instability and, ultimately, cell death in tumor cells with homologous recombination repair deficiency2–4.